◆ Drug types: innovative chemical drugs, peptide and antibody drugs, antibody-drug conjugates, etc. Qualitative/quantitative analysis of unchanged drugs and their metabolites and comprehensively interpretation of the ADME properties of drugs for IND and NDA applications.

◆ Small molecule bioanalysis: analysis on multiple types of test articles, such as conventional small molecule compounds, peptides, liposomes, and nucleic acids.

◆ Large molecule bioanalysis: multiple in vivo drug concentration determining platforms for biotechnology-based drugs, such as conventional fusion proteins, monoclonal antibodies, bispecific antibodies, ADCs, PDCs, and nucleic acids.

◆ Formulation preparation and analysis: preparation of multiple types of test formulations, including small molecule compounds, peptides, liposomes, nucleic acids, etc. Rapid detection of small molecule drug concentration by high-performance liquid chromatography (HPLC), and detection of large molecule sample concentration by HPLC-ECS.